Page last updated: 2024-10-29

ketanserin and Alcoholic Liver Diseases

ketanserin has been researched along with Alcoholic Liver Diseases in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibson, PR1
Fraser, JR1
Colman, JC1
Jones, PA1
Jennings, G1
Dudley, FJ1

Trials

1 trial available for ketanserin and Alcoholic Liver Diseases

ArticleYear
Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion.
    Gastroenterology, 1993, Volume: 105, Issue:2

    Topics: Aged; Hemodynamics; Humans; Hyaluronic Acid; Ketanserin; Liver Circulation; Liver Diseases, Alcoholi

1993